Lack of strong immune selection pressure by the immunodominant, HLA- A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2559-2566

  Brander, Christian ^a   Hartman, Kelly E ^a   Trocha, Alicja K ^a   Jones, Norman G ^a   Johnson, R Paul ^a,b   Korber, Bette ^c   Wentworth, Peggy ^d   Buchbinder, Susan P ^e   Wolinsky, Steven ^f   Walker, Bruce D ^a   Kalams, Spyros A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d CYTEL CORPORATION   (United States)

^e AIDS Office San Francisco   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AIDS; Antigen processing; Escape; Immunodominance; Variant

Indexed keywords

EPITOPE;

ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY; DNA SEQUENCE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN VARIANT; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

EID: 0032102284     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2405     Document Type: Article

References (67)

1. Walker, B.D., S. Chakrabarti, B. Moss, T.J. Paradis, T. Flynn, A.G. Durno, R.S. Blumberg, J.C. Kaplan, M.S. Hirsch, and R.T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 328: 345-348.
2. Plata, F., B. Autran, L.P. Martins, H.S. Wain, M. Raphael, C. Mayaud, M. Denis, J.M. Guillon, and P. Debre. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature. 328:348-351.
3. Borrow, P., H. Lewicki, B.H. Hahn, G.M. Shaw, and M.B.A. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
4. Klein, M.R., C.A. van Baalen, A.M. Holwerda, S.R. Kerkhof Garde, R.J. Bende, I.P.M. Keet, J.K.M. Eeftinck-Schattenkerk, A. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1356-1372.
5. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
6. Goulder, P.J., R.E. Phillips, R.A. Colbert, S. McAdam, G. Ogg, M.A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
7. Wolinsky, S.M., B.T. Korber, A.U. Neumann, M. Daniels, K.J. Kunstman, A.J. Whetsell, M.R. Furtado, Y. Cao, D.D. Ho, J.T. Safrit, and R.A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science. 272:537-542.
8. Rammensee, H.G., K. Falk, and O. Roetzschke. 1993. MHC molecules as peptide receptors. Curr. Opin. Immunol. 5:35-14.
9. Yang, O.O., S.A. Kalams, A. Trocha, H. Cao, A. Luster, R.P. Johnson, and B.D. Walker. 1997. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class 1-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.
10. Borrow, P., H. Lewicki, X. Wei, M.S. Horwitz, N. Peffer, H. Meyers, J.A. Nelson, J.E. Gairin, B.H. Hahn, M.B. Oldstone, and G.M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
11. Wain-Hobson, S. 1993. The fastest genome evolution ever described: HIV variation in situ. Curr. Opin. Gen. Devel. 3:878-883.
12. Mellors, J.W., C.R. Rinaldo, Jr., P. Gupta, R.M. White, J.A. Todd, and L.A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1167-1170.
13. Price, D.A., P.J.R. Goulder, P. Klenerman, A. Sewell, P.J. Easterbrook, M. Troop, C.R.M. Bangham, and R.E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA. 94:1890-1895.
14. Coffin, J.M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science. 267:483-488.
15. Safrit, J.T., C.A. Andrews, T. Zhu, D.D. Ho, and R.A. Koup. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
16. Meyerhans, A., G. Dadaglio, J.P. Vartanian, P. Langlade-Demoyen, R. Frank, B. Asjo, F. Plata, and S. Wain-Hobson. 1991. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21:2637-2640.
17. Nietfield, W., M. Bauer, M. Fevrier, R. Maier, B. Holzwarth, R. Frank, B. Maier, Y. Riviere, and A. Meyerhans. 1995. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. J. Immunol. 154: 2189-2197.
18. Chen, Z.W., L. Shen, M.D. Miller, S.H. Ghim, A.L. Hughes, and N.L. Letvin. 1992. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 149:4060-4066.
19. Trimble, L.A., and J. Lieberman. 1998. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3ζ, the signaling chain of the T cell receptor complex. Blood. In press.
20. Rosenberg, E.S., J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker. 1997. Vigorous HIV-1 specific CD4+ T cell responses associated with control of viremia. Science. 278:1447-1450.
21. Buchbinder, S.P., M.H. Katz, N.A. Hessol, J. Liu, P.M. O'Malley, and M.J. Alter. 1994. Hepatitis C virus infection in sexually active homosexual men. J. Infect. Dis. 29:263-269.
22. Krausa, P., D. Barouch, J.G. Bodmer, A.V. Hill, C. Mason, A.J. McMichael, and M.J. Browning. 1995. Characterization of a novel HLA-A2 variant, A*0214, by ARMS-PCR and DNA sequencing. Immunogenetics. 41:50.
23. Browning, M., and P. Krausa. 1996. Genetic diversity of HLA-A2: evolutionary and functional significance. Immunol. Today. 17:165-170.
24. Bodmer, J.G., S.G.E. Marsh, E.D. Albert, W.F. Bodmer, R.E. Bontrop, D. Charron, B. Dupont, H.A. Erlich, B. Mach, and W.R. Mayr. 1995. Nomenclature for factors of the HLA system. Tissue Antigens. 46:1-18.
25. Castano, A.R., and J.A. Lopez de Castro. 1991. Structure of the HLA-A*0204 antigen, found in South American Indians. Spatial clustering of the HLA-A2 subtype polymorphism. Immunogenetics. 34:281-285.
26. Walker, B.D., C. Flexner, T.J. Paradis, T.C. Fuller, M.S. Hirsch, R.T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science. 240:64-66.
27. Atherton, E., C.J. Logan, and R.C. Sheppard. 1981. Procedures for solid-phase peptide synthesis using N-fluorenylmethoxycarbonylamino-acids on polyamid supports. Synthesis of substance P and of acyl carrier protein. Chem. Soc. Perkin Trans. 1:538-546.
28. Tsomides, T.J., B.D. Walker, and H.N. Eisen. 1991. An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA. 88:11276-11280.
29. Tsomides, T.J., A. Aldovini, R.P. Johnson, B.D. Walker, R.A. Young, and H.N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 180:1283-1293.
30. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R.P. Johnson, S. Buchbinder, and B.D. Walker. 1996. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173:476-179.
31. Walker, B.D. 1990. HIV-1-specific cytotoxic T lymphocytes. In Techniques in HIV Research. A. Aldovini and B.D. Walker, editors. Stockton Press, New York. 201.
32. Kalams, S.A., R.P. Johnson, A.K. Trocha, M.J. Dynan, H.S. Ngo, R.T. DAquila, J.T. Kurnick, and B.D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
33. Lefkovits, I., and H. Waldmann. 1974. Limiting dilution analysis of cells of the immune system. Cambridge University Press, Cambridge. 38-204.
34. de St. Groth, F. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods. 49:11-23.
35. Finney, D.I. 1978. Assays based on quantal responses. 3rd ed. In Statistical Method in Biological Assay. Charles Griffen & Co. LTD., London. 371-403.
36. Sette, A., J. Sidney, M.F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H.M. Grey, and R.T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813-822.
37. Meyers, G., B. Foley, J.W. Mellors, B. Korber, K. Jeang, and S. Wain-Hobson. 1996. Human Retroviruses and AIDS Database. Theoretical Biology, Los Alamos National Laboratories, Los Alamos, NM.
38. Johnson, R.P., A. Trocha, L. Yang, G.P. Mazzara, D.L. Panicali, T.M. Buchanan, and B.D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
39. Walker, B.D., C. Flexner, K. Birch-Limberger, L. Fisher, T.J. Paradis, A. Aldovini, R. Young, B. Moss, and R.T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:9514-9518.
40. Brander, C., and B.D. Walker. 1996. The HLA class I restricted CTL response in HIV infection: systematic identification of optimal epitopes. In HIV Molecular Immunology Database. C.B.B. Korber, B. Walker, R. Koup, J. Moore, B. Haynes, G. Meyers, editors. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM.
41. Korber, B., B. Walker, C. Brander, R. Koup, J. Moore, B. Haynes, and G. Meyers. 1996. HIV Molecular Immunology Database 1996. Los Alamos National Laboratory: Theoretical Biology and Biophysics. Los Alamos, NM.
42. Hadida, F., G. Haas, N. Zimmermann, A. Hosmalin, R. Spohn, A. Samri, G. Jung, P. Debre, and B. Autran. 1995. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. J. Immunol. 154: 4174-4186.
43. Dupuis, M., S.K. Kundu, and T.C. Merigan. 1995. Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein. J. Immunol. 155:2232-2239.
44. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
45. Kalams, S.A., R.P. Johnson, M.J. Dynan, K.E. Hartman, T. Harrer, E. Harrer, A.K. Trocha, W.A. Blattner, S.P. Buchbinder, and B.D. Walker. 1996. T cell receptor (TCR) usage and fine specificity of HIV-1-specific cytotoxic T lymphocyte (CTL) clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J. Exp. Med. 183:1669-1679.
46. Aebischer, T., D. Moskophidis, U.H. Rohrer, R.M. Zinkernagel, and H. Hengartner. 1991. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 88: 11047-11051.
47. Bertoletti, A., A. Costanzo, F.V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933-943.
48. Koup, R.A. 1994. Virus escape from CTL recognition. J. Exp. Med. 180: 779-782.
49. Pircher, H., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner, and R.M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:629-633.
50. Weiner, A., A.L. Erikson, J. Kansopon, K. Crawford, E. Muchmore, A. Hughes, M. Houghton, and C.M. Walker. 1994. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA. 92:2755-2759.
51. Goulder, P.J.R., A.K. Sewell, D.G. Lalloo, D.A. Price, J.A. Whelan, J. Evans, G.P. Taylor, G. Luzzi, P. Giangrande, R.E. Phillips, and A.J. McMichael. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses on two human histocompatibility leukocyte antigen identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423-1433.
52. Wu, T.T., and E.A. Kabat. 1970. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132:211-250.
53. Phillips, R.E., S. Rowland-Jones, D.F. Nixon, F.M. Gotch, J.P. Edwards, A.O. Ogunlesi, J.G. Elvin, J.A. Rothbard, C.R. Bangham, C.R. Rizza, et al. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:453-459.
54. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129-1134.
55. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W.M. Kast, C.J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
56. Ruppert, J., J. Sidney, E. Celis, R.T. Kubo, H.M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:929-937.
57. Brander, C., W.J. Pichler, and G. Corradin. 1995. Identification of HIV-protein derived CTL epitopes for their potential use as synthetic vaccine. Clin. Exp. Immunol. 101:107-113.
58. Borysiewicz, L.K., S. Graham, J.K. Hickling, P.D. Mason, and J.G. Sissons. 1988. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur. J. Immunol. 18:269-275.
59. de Campos-Lima, P.O., R. Gavioli, Q.J. Zhang, L.E. Wallace, R. Dolcetti, M. Rowe, A.B. Rickinson, and M.G. Masucci. 1993. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science. 260:98-100.
60. Klenerman, P., U.C. Meier, R.E. Phillips, and AJ. McMichael. 1995. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur. J. Immunol. 25: 1927-1931.
61. Clerici, M., and G.M. Shearer. 1993. A TH1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:107-110.
62. Niedermann, G., S. Butz, H.G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity. 2:289-299.
63. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes, 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196-3206.
64. Heemels, M., and H.L. Ploegh. 1994. Substrate specificity of allelic variants of the TAP peptide transporter. Immunity. 1:775-784.
65. Driscoll, J., M.G. Brown, D. Finlay, and J.J. Monaco. 1993. MHC-linked LMP gene products specifically alter pcptidasc activities of the proteasome. Nature. 365:262-264.
66. Yang, O.O., S.A. Kalams, M. Rosenzweig, A. Trocha, N. Jones, M. Koziel, B.D. Walker, and R.P. Johnson. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70:5799-5806.
67. Perelson, A.S., A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1582-1586.